These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 16916808
1. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons. Masunaga S, Sakurai Y, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Nagasawa H, Uto Y, Hori H, Ono K. Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808 [Abstract] [Full Text] [Related]
2. The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose-rate irradiation with gamma-rays. Masunaga S, Nagasawa H, Uto Y, Hori H, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K. Int J Hyperthermia; 2007 Feb; 23(1):29-35. PubMed ID: 17575721 [Abstract] [Full Text] [Related]
3. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo. Masunaga S, Tano K, Watanabe M, Kashino G, Suzuki M, Kinashi Y, Ono K, Nakamura J. Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181 [Abstract] [Full Text] [Related]
4. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857 [Abstract] [Full Text] [Related]
5. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H. Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967 [Abstract] [Full Text] [Related]
6. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status. Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H. Cancer Sci; 2003 Jan 01; 94(1):125-33. PubMed ID: 12708486 [Abstract] [Full Text] [Related]
7. Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential. Masunaga S, Liu Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K. Int J Hyperthermia; 2012 Jan 01; 28(7):636-44. PubMed ID: 22946564 [Abstract] [Full Text] [Related]
8. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment. Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y. Br J Radiol; 2000 Sep 01; 73(873):978-86. PubMed ID: 11064652 [Abstract] [Full Text] [Related]
9. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Masunaga SI, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, Hori H, Nagasawa H, Uto Y, Tsuchiya I, Sadahiro S, Murayama C. Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):1063-72. PubMed ID: 11429234 [Abstract] [Full Text] [Related]
10. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells. Masunaga SI, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y. Jpn J Cancer Res; 2000 May 15; 91(5):566-72. PubMed ID: 10835503 [Abstract] [Full Text] [Related]
11. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound. Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M. Int J Radiat Oncol Biol Phys; 2000 Feb 01; 46(3):653-9. PubMed ID: 10701745 [Abstract] [Full Text] [Related]
12. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M. Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):828-39. PubMed ID: 11697329 [Abstract] [Full Text] [Related]
13. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia. Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y. Radiat Med; 1998 Nov 01; 16(6):441-8. PubMed ID: 9929144 [Abstract] [Full Text] [Related]
14. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia. Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M. Br J Radiol; 1997 Apr 01; 70(832):391-8. PubMed ID: 9166076 [Abstract] [Full Text] [Related]
15. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells. Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H. Jpn J Cancer Res; 2001 Sep 01; 92(9):996-1007. PubMed ID: 11572769 [Abstract] [Full Text] [Related]
16. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments. Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y. Radiat Med; 1999 Sep 01; 17(4):259-64. PubMed ID: 10510897 [Abstract] [Full Text] [Related]
17. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams. Masunaga S, Ando K, Uzawa A, Hirayama R, Furusawa Y, Koike S, Sakurai Y, Nagata K, Suzuki M, Kashino G, Kinashi Y, Tanaka H, Maruhashi A, Ono K. Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):221-8. PubMed ID: 18086390 [Abstract] [Full Text] [Related]
18. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells. Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y. Int J Hyperthermia; 1999 Jan 01; 15(1):7-16. PubMed ID: 10193753 [Abstract] [Full Text] [Related]
19. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios. Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Suzuki M, Kinashi Y, Akaboshi M. Int J Radiat Oncol Biol Phys; 1998 Jul 15; 41(5):1163-70. PubMed ID: 9719128 [Abstract] [Full Text] [Related]
20. Applicability of combination with tirapazamine in boron neutron capture therapy. Masunaga S, Ono K, Sakurai Y, Hori H, Kobayashi T, Takagaki M, Suzuki M, Kinashi Y, Akaboshi M. Jpn J Cancer Res; 1998 Jul 15; 89(7):768-74. PubMed ID: 9738984 [Abstract] [Full Text] [Related] Page: [Next] [New Search]